(Nova York - EUA, 24/09/2019) Presidente da República, Jair Bolsonaro, durante encontro com o senhor Rudolph Giuliani, ex-prefeito da cidade de Nova York. .Foto: Alan Santos/PR
Former New York City Mayor Rudy Giuliani has reportedly left the intensive care unit, according to his spokesperson, after being hospitalized with pneumonia.
Giuliani “will spend some time recovering before leaving the hospital,” spokesperson Ted Goodman said in a statement, adding: “The mayor and his family appreciate the outpouring of love and prayers sent his way.”
Giuliani had been hospitalized in critical condition earlier this week, his spokesperson said Sunday.
Dr. Maria Ryan told Fox News that Giuliani’s condition had deteriorated rapidly after he returned from a trip to Paris, with severe breathing issues forcing doctors to place him on a ventilator. At one point, his situation became so dire that a priest was called to administer last rites.
But by Tuesday, everything changed.
“He’s a fighter — the way he was yesterday in such a critical condition, he did have a priest come anoint him,” Ryan said. “And all the prayers from around — it’s like a miracle. This guy’s got 9 lives, today he’s doing much better.”
Goodman said Giuliani was previously diagnosed with restrictive airway disease, which he said was a result of his proximity to the collapsed World Trade Center towers on Sept. 11, 2001.
“This condition adds complications to any respiratory illness, and the virus quickly overwhelmed his body, requiring mechanical ventilation to maintain adequate oxygen and stabilize his condition,” Goodman said Monday.
By The White House - https://www.flickr.com/photos/202101414@N05/54581054338/, Public Domain,
White House press secretary Karoline Leavitt addressed concerns over President Donald Trump’s health during a briefing on Thursday after photographs of his hand appearing bruised and his ankles appearing swollen went viral.
Why is Donald Trump covering bruises on his hands with cake makeup and why isn’t anyone in the press asking him about it? pic.twitter.com/Bk9Ve0rqhH
“I know that many in the media have been speculating about bruising on the president’s hand, and also swelling in the president’s legs. So in the effort of transparency, the president wanted me to share a note from his physician with all of you today,” began Leavitt before reading from the note:
In recent weeks, President Trump noted mild swelling in his lower legs. In keeping with routine medical care and out of an abundance of caution, this concern was thoroughly evaluated by the White House Medical Unit. The president underwent a comprehensive examination, including diagnostic vascular studies. Bilateral lower extremity venous Doppler ultrasounds were performed and revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70.
Importantly, there was no evidence of deep vein thrombosis or arterial disease. Laboratory testing included a complete blood count, comprehensive metabolic panel, coagulation profile, D-dimer, B-type, natriotic, peptide, and cardiac biomarkers. All results were within normal limits. An echocardiogram was also performed, and confirmed normal cardiac structure and function. No signs of heart failure, renal impairment, or systemic illness were identified.
Additionally, recent photos of the president have shown minor bruising on the back of his hand. This is consistent with minor soft tissue irritation from frequent handshaking, and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen. This is a well-known and benign side effect of aspirin therapy, and the president remains in excellent health.
“Which I think all of you witness on a daily basis here,” added Leavitt. “So the president wanted me to share that note with all of you. I’m happy to take further questions on it. We will provide the memorandum from the president’s physician to all of you, as we always do.
Watch:
🚨 JUST IN: President Trump has been diagnosed with chronic venous insufficiency, following reports of swelling in the President's legs, per Karoline Leavitt
Luckily, it's nothing serious.
THIS IS HOW IT SHOULD BE HANDLED. NOT covered up like Joe Biden's illnesses!
The White House, Public domain, via Wikimedia Commons
President Donald Trump has selected Dr. Heidi Overton, a senior White House domestic policy adviser and physician, to lead the Food and Drug Administration as the agency confronts battles over vaccines, drug prices, food additives, and abortion medication.
Trump announced the nomination Wednesday, describing Overton as a trusted problem-solver who would accelerate medical innovation, lower prescription costs, and advance Health and Human Services Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” agenda.
Overton currently serves as deputy director of the White House Domestic Policy Council, where she has helped formulate and promote several of the administration’s most consequential health initiatives.
BREAKING: President Trump picks Dr. Heidi Overton, a top White House aide, to lead the Food and Drug Administration. https://t.co/fGVJ7TNQjt
If confirmed by the Senate, she would succeed Dr. Marty Makary, who left the agency in May after a turbulent tenure marked by internal disputes and disagreements over the direction of federal health policy.
Kyle Diamantas, who previously led the FDA’s Human Foods Program, is serving as acting commissioner.
A Physician With Deep White House Ties
Overton is a board-certified physician in public health and general preventive medicine. She earned her medical degree from the University of New Mexico School of Medicine and a doctorate in clinical investigation from the Johns Hopkins Bloomberg School of Public Health.
She previously trained as a general surgery resident at Johns Hopkins and advocated for greater price and quality transparency in health care.
During medical school, then-New Mexico Gov. Susana Martinez appointed Overton to the University of New Mexico Board of Regents, where she held voting and fiduciary responsibility for the university and its health system.
Overton first entered the Trump White House as a fellow in 2019, working in the Office of American Innovation and on the Domestic Policy Council. Between Trump’s terms, she served as chief policy officer at the America First Policy Institute and helped lead its Center for a Healthy America.
Her biography from the conservative organization emphasizes her work on health-care transparency, fentanyl, public health and policies designed to give patients greater control over medical decisions.
The appointment would place a committed administration loyalist at the head of an agency that regulates products representing roughly one-fifth of American consumer spending.
Overton Helped Shape Trump’s Health Agenda
Overton has appeared alongside Trump during major health policy announcements, including the administration’s efforts to negotiate “most favored nation” agreements with drug companies. The policy seeks to tie American prescription prices to the lower prices paid in other developed countries.
She was also involved in Trump’s controversial effort to revise the childhood vaccination schedule and separate the combined measles, mumps and rubella vaccine into three individual shots.
Major medical organizations have generally supported the combined MMR vaccine, which has been used for decades and reduces the number of clinical visits and injections required for full immunization. Critics fear that splitting the vaccine could create delays and lower vaccination rates.
Overton’s role in the policy is likely to become a focus of her Senate confirmation hearing, particularly as lawmakers question how she would handle pressure from Kennedy and other administration figures skeptical of established federal vaccine recommendations.
Trump praised Overton as a “rockstar” who would advance medical cures, innovation and lower drug prices.
Kennedy also supports the nomination, giving Overton an important ally inside the Department of Health and Human Services, which oversees the FDA.
Difficult Issues Await New Commissioner
The next FDA commissioner will inherit an unusually difficult collection of unfinished projects.
The agency continues to face pressure over its regulation of COVID-19 vaccines and other immunizations, including questions about which populations should receive updated shots and what evidence manufacturers must provide.
Medication abortion will present another immediate test. Pro-life organizations want the FDA to impose tighter restrictions on mifepristone, including limits on prescriptions issued through telehealth and pills delivered through the mail.
Overton has previously used the term “teleabortion” when discussing remote access to abortion medication, drawing concern from abortion-rights organizations that expect her to revisit the drug’s rules.
The FDA must also determine how aggressively it will regulate ultraprocessed foods, chemical additives, and synthetic dyes. Those issues are central to Kennedy’s MAHA movement but can conflict with the deregulatory approach traditionally favored by Republican lawmakers and industry groups.
Other pending questions involve flavored electronic cigarettes, peptide treatments, psychedelics, antidepressant warnings, and efforts to shorten the approval process for new drugs.
Overton would therefore have to balance three competing forces: Trump’s desire for faster approvals and lower prices, Kennedy’s campaign against corporate influence in food and medicine, and Republican demands for reduced federal regulation.
Management Experience Likely to Draw Scrutiny
Overton’s supporters point to her medical education, policy background, and proximity to presidential decision-making. They argue that she understands Trump’s priorities and can coordinate more effectively with the White House than an outside nominee.
Critics are expected to focus on her limited experience running an organization comparable to the FDA.
The agency employs thousands of scientists, physicians, inspectors, lawyers, and regulatory specialists. It oversees prescription drugs, medical devices, vaccines, tobacco products, much of the nation’s food supply, and other consumer goods.
Axios reported before her selection that some health policy observers worried Overton’s nomination could unsettle FDA career employees and pharmaceutical investors, while other potential candidates possessed more direct executive management experience.
The criticism will likely feature prominently when she appears before the Senate Health, Education, Labor and Pensions Committee.
Makary, Overton’s predecessor and a former Johns Hopkins colleague, was confirmed in March 2025 by a 56-44 Senate vote. Overton will seek confirmation from a chamber still controlled by Republicans but divided over the administration’s vaccine policies.
Her nomination signals that Trump wants the FDA led by someone already embedded in his White House rather than an agency insider or pharmaceutical executive.
If the Senate agrees, Overton will take control of one of the federal government’s most powerful scientific agencies — and become responsible for turning the administration’s sprawling health agenda into enforceable policy.
On the evening of Tuesday, June 17, 2025, Homeland Security Secretary Kristi Noem was rushed by ambulance to a Washington, D.C. hospital after suffering what officials described as an allergic reaction. According to a statement from the Department of Homeland Security (DHS), Noem was treated “out of an abundance of caution” and remains in stable condition.
The medical emergency drew swift attention — not only because of Noem’s high-profile cabinet role, but also due to the timing. Just one day earlier, she had visited the Integrated Research Facility at Fort Detrick, Maryland, a high-security federal lab that handles some of the world’s most dangerous pathogens, including Ebola and SARS-CoV-2. She was accompanied on the tour by Health and Human Services Secretary Robert F. Kennedy Jr. and Senator Rand Paul (R-Ky.).
The Fort Detrick facility has been under scrutiny in recent months. In April, it was temporarily shut down following safety concerns involving possible tampering with personal protective equipment. Though the lab has since resumed operations, the incident left lingering questions about oversight and internal protocols.
While the proximity of Noem’s hospital visit to her tour of the lab has sparked speculation, DHS downplayed any connection. Officials stressed there is no indication the allergic reaction had anything to do with the biohazard site, and current evidence points to coincidence, not causation.
Still, the lack of detail surrounding Noem’s condition — and the decision to visit to a facility recently flagged for a safety lapse — has fueled speculation. Noem has not issued a public statement since the incident, though an official told the Associated Press that the secretary is “alert and recovering.”
Security around the hospital was visibly heightened following Noem’s arrival, with multiple eyewitnesses reporting Secret Service personnel stationed at emergency entrances and perimeter points.
As of now, Noem remains under medical supervision, and DHS has indicated she will resume duties once cleared by her doctors. The department has not disclosed whether additional tests are being conducted to rule out environmental or chemical triggers.
What We Know — and Don’t
The facts are straightforward, even if the full picture isn’t: Secretary Noem had an acute medical event. She had just visited a facility known for housing lethal biological agents. There’s no official link between the two events. But in an era when institutional trust runs thin and information gaps invite conspiracy theories, the sequence of events is likely to keep this story alive longer than a typical health scare.
For now, DHS says Noem is recovering and expected to make a full recovery. But until more details emerge — from medical professionals or Noem herself — the story will likely remain a focus of intense public interest.
Lee made the remarks when asked about McConnell’s prolonged absence from the Senate, saying rank-and-file lawmakers have received few details beyond the limited public statements released by McConnell’s office.
‘Most Of Us Don’t Know’
Lee acknowledged that speculation has grown because so little official information has been released.
His comments contrast with earlier remarks from Senate Majority Leader John Thune, who previously said McConnell “sounded good” during a recent conversation. Lee indicated that most senators have not received similar updates and remain largely in the dark about their colleague’s condition.
Office Continues To Release Limited Information
McConnell’s office has consistently maintained that the 84-year-old senator is recovering and remains engaged with Senate business.
In its latest public statement, spokesman David Popp said McConnell “continues to improve” and is working with staff on Kentucky and Senate matters while Congress is in recess. The office has not disclosed his diagnosis, prognosis, or expected discharge date.
Medical Emergency Prompted Questions
McConnell has not appeared publicly since June 14, when emergency responders were dispatched to his Washington residence.
Emergency dispatch audio reviewed by multiple news organizations described an unconscious patient and referenced CPR in progress. McConnell’s office has not confirmed the specific medical event that led to his hospitalization.
The absence of detailed updates has fueled intense online speculation, including unverified claims promoted by White House confidant Laura Loomer. McConnell’s office has offered no support for those assertions, saying only that the senator continues to improve.
Questions Persist As Senate Recess Continues
The Senate remains in recess until later this month, giving McConnell additional time to recover before lawmakers return to Washington.
Whether he will be able to resume his duties when the Senate reconvenes remains unclear. McConnell previously announced he will not seek reelection and plans to retire when his current term expires in January 2027.
For now, Lee’s comments highlight what many senators have acknowledged privately: beyond the brief statements released by McConnell’s aides, even many of his Republican colleagues say they know little about his current condition.
President Donald Trump is facing pressure to use his executive power to block hospitals from denying organ transplants for people not vaccinated against COVID-19 after reports emerged that Vice President JD Vance’s 12-year-old relative was reportedly denied a heart transplant over her COVID-19 vaccination status
In a letter to President Trump, Rep. Michael Rulli (R-Ohio) alongside Rep. Erin Houchin (R-Ind.) called on Trump to take action. Rep. Rulli said he was partially moved to act after hearing about Vance’s relative.
“Over the past week, it has come to light that multiple desperate Americans have been denied life-saving organ transplants due to their COVID-19 vaccination status,” the letter said. “This outrageous denial of care has affected some of our most vulnerable citizens – including a child from Indiana and a veteran from Ohio.”
Houchin told Fox News, “Patients – especially children – should never be turned away from care due to government-imposed mandates. This effort urges President Trump to take action to ensure no hospital or transplant center can discriminate against patients based on their decision to decline the COVID-19 vaccine.”
“President Trump has done such a great job recently on executive orders,” Rulli told Fox News Digital in an interview. “And I am asking President Trump if he sees this, to please do an executive order… because you could save someone’s life today.”
“The timing is everything. If we don’t get this done, people’s lives could be at risk.”
The girl’s mother, Jeneen Deal, told the Daily Mail that giving her daughter the vaccine would violate the family’s religious beliefs.
Vance said in comments to the Daily Mail that he would try to help.
“I guess it’s been circulating on social media, but I was made aware of a couple days ago, and we’re trying to dig in and trying to help, obviously, as much as possible,” he said.
Fox News anchor John Roberts has revealed he’s been hospitalized after contracting what he described as a “severe case of malaria,” sidelining him from his weekday slot on America Reports.
“I somehow came down with a severe case of malaria,” Roberts, 68, announced via X on Tuesday. “I can honestly say that I am the only person in the hospital with malaria. In fact, one of my doctors said I’m the first case he has ever seen.”
Thank you to Trace for jumping into the chair today! I somehow came down with a severe case of Malaria. I can honestly say that I am the only person in the hospital with Malaria. In fact, one of my doctors said I’m the first case he has ever seen. Thanks to the folks at… https://t.co/6ZHiB5Dv8v
Malaria was eliminated from the U.S. in 1951, according to the CDC. However, the country still sees about 2,000 malaria cases per year. There were, on average, nearly seven deaths per year between 2007 and 2022.
Malaria cases in the U.S. are now mostly linked to international travel.
Malaria is spread by mosquitoes. Cases in the U.S. were typically in people who traveled to or from countries where the disease is widespread. The CDC said locally acquired, mosquito-transmitted malaria is “rare” in the country.
Malaria patients often reported having recently returned from Africa, the CDC said. Patients commonly reported visiting friends and family as their primary reason for travel.
President Donald Trump said Monday that White House physicians helped treat Rep. Neal Dunn, a Florida Republican, after the congressman received what Trump described as a “terminal” medical diagnosis — an episode Trump and House Speaker Mike Johnson framed as a dramatic intervention that helped save Dunn’s life.
The president and Johnson recounted the story during remarks at the White House, saying Dunn had continued working in Congress despite what they characterized as a dire prognosis.
“He would be dead by June,” Trump told reporters, describing the severity of the diagnosis Dunn had reportedly received before receiving treatment.
Johnson said the situation came to Trump’s attention after he informed the president about Dunn’s condition. According to Johnson, Trump quickly suggested involving White House medical staff to evaluate the congressman.
“The man has a new lease on life. He acts like he’s 30 years younger,” Johnson said, describing Dunn’s recovery after treatment.
Johnson explained that White House physicians helped coordinate care for the Florida lawmaker and arranged for him to receive treatment at Walter Reed National Military Medical Center, the premier military hospital that frequently treats senior government officials and members of Congress.
According to Johnson, Dunn underwent emergency surgery shortly after the White House doctors became involved.
Trump praised the speed and professionalism of the medical team, calling the White House physicians “miracle workers.”
“I said, I have to call them. And I called the two doctors. They’re both great. And they immediately went over to see the congressman, and he was on the operating table like two hours later,” Trump added.
Dunn, who represents Florida’s 2nd Congressional District in the state’s Panhandle, is himself a physician. Before entering politics, he served as an Army surgeon and later worked in private medical practice. His medical background has often shaped his work in Congress, particularly on issues involving healthcare policy and veterans’ services.
First elected in 2016, Dunn has served five terms in the House of Representatives and has been a reliable conservative vote on fiscal issues, national defense, and social policy.
In January, Dunn announced that he would not seek reelection in 2026, signaling the end of his congressional career. At the time, he framed the decision as an opportunity to step away from Washington and spend more time with his family.
“I want to pass the torch to new conservative leaders, return home to Panama City, and spend more precious time with my family and our beloved grandchildren,” Dunn said in a statement announcing his retirement.
He also reflected on his legislative priorities during his time in Congress.
“It has been my greatest honor to fight for lower taxes, our military and veterans, the unborn, healthcare innovation, and policies that empower Americans over bureaucracy and addressing threats from Communist China, Russia and others,” he added.
Dunn’s departure comes during a cycle that is already seeing a significant number of lawmakers opt not to run again. As of mid-March, 60 House members have announced they will not seek reelection in the 2026 election cycle, according to the U.S. House of Representatives Press Gallery’s “Casualty List.”
That total includes 23 Democrats and 37 Republicans.
Several of those lawmakers are leaving to pursue other offices, including gubernatorial and U.S. Senate bids. Others are retiring outright after years in public service.
Among Republicans, some departures have come through electoral defeat. Rep. Dan Crenshaw of Texas, for example, recently lost his primary race to state Rep. Steve Toth.
While Dunn’s decision to retire was announced before the details of his health episode were publicly discussed, the account shared by Trump and Johnson Monday offered new insight into the medical crisis he faced earlier this year — and the role White House doctors played in coordinating the emergency treatment that both men say dramatically improved his outlook.
Former Senate Republican Leader Mitch McConnell was admitted to a hospital Sunday morning, according to his office, marking the latest health-related setback for the 84-year-old Kentucky senator as he prepares to leave public office.
“Senator McConnell was admitted to the hospital this morning. He is receiving excellent care,” a spokesperson said in a brief statement. The senator’s office has not disclosed the reason for his hospitalization or provided details about his condition.
McConnell’s hospitalization comes just four months after he spent more than a week in the hospital for what aides described at the time as “flu-like symptoms.” His office later said he had been discharged and was recovering while working from home.
The Kentucky Republican has faced a series of highly publicized health challenges in recent years, including a concussion and broken ribs after a 2023 fall, multiple additional falls, and several incidents in which he appeared to freeze during public appearances. McConnell, a childhood polio survivor, has also acknowledged mobility issues and has at times used a wheelchair at the Capitol.
Despite those concerns, McConnell has remained active in the Senate and continues serving out his seventh term. He announced last year that he would not seek reelection and plans to retire when his term expires in January.
The U.S. Supreme Court on Thursday cleared the way for the Trump administration to move forward with nearly $800 million in cuts to National Institutes of Health grants.
The decision allows the administration to withhold funds that had been frozen by a lower court — grants largely tied to diversity, equity, and inclusion (DEI) initiatives, as well as studies focused on minority health, LGBTQ+ issues, vaccine hesitancy, COVID-19, and similar public health topics.
A federal trial court in Massachusetts had previously ruled in June that many of the cuts were “arbitrary and discriminatory,” ordering the temporary restoration of those grants.
But the Supreme Court, acting through its emergency — or so-called “shadow” — docket, overrode that ruling in a narrow 5–4 decision.
Chief Justice John Roberts sided with the liberal bloc in dissent. Justice Ketanji Brown Jackson issued a sharply worded dissent of her own, criticizing the court’s reliance on the emergency process and the brevity of the majority’s explanation.
As SCOTUSBlogreports, the court — also by a 5–4 margin — left in place another part of the lower court’s ruling affecting internal NIH guidance documents outlining the agency’s policy priorities:
Justice Amy Coney Barrett provided the key vote on each issue. She joined Justices Clarence Thomas, Samuel Alito, Neil Gorsuch, and Brett Kavanaugh in voting to allow NIH to terminate the grants, but she joined Chief Justice John Roberts and Justices Sonia Sotomayor, Elena Kagan, and Ketanji Brown Jackson in voting to leave the lower court’s ruling on the guidance documents in place.
Jackson had sharp words for her colleagues, describing the ruling as “Calvinball jurisprudence” – a reference to the Calvin and Hobbes cartoon – “with a twist. Calvinball has only one rule: There are no fixed rules. We seem to have two: that one, and this Administration always wins.”
Two separate groups of plaintiffs went to federal court in Massachusetts to challenge the termination of the grants. One group is made up of 16 states whose public universities receive funding from NIH, while the other consists of the American Public Health Association, individual researchers, a union, and a reproductive health advocacy group. They contended that the termination of the grants violated both the Constitution and the Administrative Procedure Act, the federal law governing administrative agencies.
The administration argues the research in question lacks scientific rigor and was driven more by ideology than merit. Officials also say the cuts are consistent with their broader push to eliminate DEI-related spending across federal agencies.
Democrat-led states and advocacy groups claim the funding loss could have “incalculable” consequences for underserved communities.
This case fits a broader pattern: The court has recently upheld rollbacks on DEI-based spending in areas like teacher training. Critics say the use of the emergency docket limits public transparency and bypasses full hearings. Supporters say it’s a legitimate tool to keep activist courts in check.
Legal challenges are still moving through the lower courts.
In the meantime, universities, NIH personnel, and left-leaning advocacy groups are mobilizing in protest, warning of long-term damage to public health research and institutional equity efforts.
